3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
38
Completed
34
Terminated
13
Unknown
11
Active not recruiting
7
Withdrawn
3
Enrolling by invitation
2
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Glioblastoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma
1
Rhabdoid Tumor
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Postoperative Complications
1
Pancreatic carcinoma, familial
1
Interventions
Exercise
9
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Anastrozole
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT07401355
2026-02-10
LIGHT-CTC
Centre Leon Berard
Phase NA
Not yet recruiting
100 enrolled